13F Notebook
← Dashboard
Fund detail

HHLR Advisors / Hillhouse (Zhang Lei)

china, growth, hillhouse, active

Quarters 30
2022-06-30 $4.67B
Positions 64
Showing 13 of 13 rows (filtered from 77)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 ARGENX SE $0 0 -120,000 -100.00% 0.79%
2 CHINA INDEX HLDGS LTD $0 0 -300,000 -100.00% 0.01%
3 CHINA JO-JO DRUGSTORES INC $0 0 -4,840,000 -100.00% 0.03%
4 DIDI GLOBAL INC $0 0 -36,834,320 -100.00% 1.92%
5 FANG HLDGS LTD $0 0 -327,720 -100.00% 0.02%
6 FUTU HLDGS LTD $0 0 -130,000 -100.00% 0.09%
7 HIPPO HLDGS INC $0 0 -2,771,691 -100.00% 0.12%
8 INSTIL BIO INC $0 0 -2,385,457 -100.00% 0.54%
9 LI AUTO INC $0 0 -2,496,550 -100.00% 1.35%
10 MEREO BIOPHARMA GROUP PLC $0 0 -2,976,121 -100.00% 0.07%
11 TANGO THERAPEUTICS INC $0 0 -882,088 -100.00% 0.14%
12 TSCAN THERAPEUTICS INC $0 0 -669,513 -100.00% 0.04%
13 ZTO EXPRESS CAYMAN INC $0 0 -200,000 -100.00% 0.10%